Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3727)
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
7,319
Price
$99.57
Total Value
$728.75K
Shares Held After
627,713
% of Holdings
1.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,603
Price
$98.58
Total Value
$355.18K
Shares Held After
635,032
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,247
Price
$97.68
Total Value
$219.49K
Shares Held After
638,635
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,919
Price
$96.24
Total Value
$280.92K
Shares Held After
640,882
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,648
Price
$95.12
Total Value
$156.76K
Shares Held After
643,801
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
286
Price
$94.48
Total Value
$27.02K
Shares Held After
645,449
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,179
Price
$92.14
Total Value
$200.77K
Shares Held After
645,735
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
8,990
Price
$102.48
Total Value
$921.30K
Shares Held After
3,490,653
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
6,597
Price
$101.61
Total Value
$670.32K
Shares Held After
3,499,643
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
56,348
Price
$100.17
Total Value
$5.64M
Shares Held After
3,506,240
% of Holdings
1.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
52,442
Price
$99.57
Total Value
$5.22M
Shares Held After
3,562,588
% of Holdings
1.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
25,976
Price
$98.58
Total Value
$2.56M
Shares Held After
3,615,030
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
16,084
Price
$97.68
Total Value
$1.57M
Shares Held After
3,641,006
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
20,903
Price
$96.24
Total Value
$2.01M
Shares Held After
3,657,090
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,783
Price
$95.12
Total Value
$1.12M
Shares Held After
3,677,993
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,035
Price
$94.48
Total Value
$192.27K
Shares Held After
3,689,776
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,921
Price
$92.14
Total Value
$1.37M
Shares Held After
3,691,811
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,341
Price
$104.38
Total Value
$139.97K
Shares Held After
613,762
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,560
Price
$103.42
Total Value
$264.76K
Shares Held After
615,103
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
9,584
Price
$104.38
Total Value
$1.00M
Shares Held After
3,462,756
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
18,313
Price
$103.42
Total Value
$1.89M
Shares Held After
3,472,340
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
699
Price
$82.14
Total Value
$57.42K
Shares Held After
15,312
% of Holdings
4.4%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
888
Price
$80.01
Total Value
$71.05K
Shares Held After
16,011
% of Holdings
5.3%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$99.00
Total Value
$247.50K
Shares Held After
50,195
% of Holdings
4.7%
Oncotelic Therapeutics, Inc. (OTLC)
Shah Amit B. — CFO
Shares
20,000
Price
$0.05
Total Value
$1.00K
Shares Held After
378,837
% of Holdings
5.3%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
7,340,178
Price
$0.01
Total Value
$95.42K
Shares Held After
2,406,438
% of Holdings
305.0%
CDT Equity Inc. (CDT)
Taylor Mark Andrew — 10% Owner
Shares
593,289
Price
$1.40
Total Value
$829.12K
Shares Held After
0
% of Holdings
100.0%
CDT Equity Inc. (CDT)
Taylor Mark Andrew — 10% Owner
Shares
5,000
Price
$0.75
Total Value
$3.75K
Shares Held After
593,289
% of Holdings
0.8%
CDT Equity Inc. (CDT)
Taylor Mark Andrew — 10% Owner
Shares
1,464,711
Price
$1.44
Total Value
$2.11M
Shares Held After
0
% of Holdings
100.0%
CDT Equity Inc. (CDT)
Taylor Mark Andrew — 10% Owner
Shares
5,000
Price
$0.71
Total Value
$3.53K
Shares Held After
1,464,711
% of Holdings
0.3%
Disc Medicine, Inc. (IRON)
Khara Rahul — Chief Legal Officer
Shares
500
Price
$71.62
Total Value
$35.81K
Shares Held After
52,173
% of Holdings
0.9%
Disc Medicine, Inc. (IRON)
Khara Rahul — Chief Legal Officer
Shares
1,600
Price
$70.73
Total Value
$113.16K
Shares Held After
52,673
% of Holdings
2.9%
Disc Medicine, Inc. (IRON)
Khara Rahul — Chief Legal Officer
Shares
5,400
Price
$69.94
Total Value
$377.69K
Shares Held After
54,273
% of Holdings
9.0%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
300
Price
$34.00
Total Value
$10.20K
Shares Held After
65,631
% of Holdings
0.5%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
1,551
Price
$71.61
Total Value
$111.07K
Shares Held After
226,064
% of Holdings
0.7%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
9,522
Price
$70.70
Total Value
$673.21K
Shares Held After
227,615
% of Holdings
4.0%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
22,927
Price
$69.92
Total Value
$1.60M
Shares Held After
237,137
% of Holdings
8.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
1,020
Price
$462.17
Total Value
$471.41K
Shares Held After
15,933
% of Holdings
6.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
793
Price
$92.16
Total Value
$73.08K
Shares Held After
647,914
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
4,526
Price
$91.85
Total Value
$415.71K
Shares Held After
648,707
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
8,809
Price
$90.48
Total Value
$797.04K
Shares Held After
653,233
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,672
Price
$92.16
Total Value
$522.73K
Shares Held After
3,706,732
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
32,359
Price
$91.85
Total Value
$2.97M
Shares Held After
3,712,404
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
62,897
Price
$90.48
Total Value
$5.69M
Shares Held After
3,744,763
% of Holdings
1.7%
Kura Oncology, Inc. (KURA)
Leoni Mollie — Chief Medical Officer
Shares
84,929
Price
$9.82
Total Value
$834.28K
Shares Held After
182,345
% of Holdings
31.8%
NovaBridge Biosciences (NBP)
Dennis Phillip Andrew — Chief Medical Officer
Shares
8,494
Price
$0.66
Total Value
$5.61K
Shares Held After
157,941
% of Holdings
5.1%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
46,901
Price
$20.07
Total Value
$941.37K
Shares Held After
4,112,218
% of Holdings
1.1%
VERACYTE, INC. (VCYT)
EASTHAM KARIN — Director
Shares
529
Price
$53.55
Total Value
$28.33K
Shares Held After
15,097
% of Holdings
3.4%
VERACYTE, INC. (VCYT)
EASTHAM KARIN — Director
Shares
3,200
Price
$52.78
Total Value
$168.91K
Shares Held After
15,626
% of Holdings
17.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
660
Price
$548.90
Total Value
$362.28K
Shares Held After
18,876
% of Holdings
3.4%
Showing 1401–1450 of 3727 transactions (page 29 of 75)